DRI Capital To Pursue Phase III Assets With Some Of Its Third Royalty Fund
This article was originally published in The Pink Sheet Daily
Executive Summary
Toronto-based health care royalty acquirer raises a $1.45 billion third fund, which it says should last between three-and-a-half and five years. It is mainly sticking with its prior investment strategy, although for the first time DRI will look at acquiring royalty rights to promising Phase III candidates.